These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

75 related articles for article (PubMed ID: 18393971)

  • 1. Proliferation and apoptosis of tumour cells before and after neoadjuvant therapy for high-grade extremity sarcomas: divergent associations with tumour response and prognosis.
    Matsubara T; Eimoto T; Okabe M; Miyabe S; Fujiyoshi Y; Matsushita Y; Mizutani J; Yamada S; Otsuka T
    Histopathology; 2008 May; 52(6):706-16. PubMed ID: 18393971
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Histologic alterations from neoadjuvant chemotherapy in high-grade extremity soft tissue sarcoma: clinicopathological correlation.
    Lucas DR; Kshirsagar MP; Biermann JS; Hamre MR; Thomas DG; Schuetze SM; Baker LH
    Oncologist; 2008 Apr; 13(4):451-8. PubMed ID: 18448561
    [TBL] [Abstract][Full Text] [Related]  

  • 3. MR-imaging changes of musculoskeletal soft-tissue sarcomas associated with neoadjuvant chemotherapy and hyperthermia.
    Baur A; Stäbler A; Wendtner CM; Arbogast S; Rahman SA; Santl M; Issels R; Reiser M
    Int J Hyperthermia; 2003; 19(4):391-401. PubMed ID: 12850925
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cell proliferation marker MCM2, but not Ki67, is helpful for distinguishing between minimally invasive follicular carcinoma and follicular adenoma of the thyroid.
    Cho Mar K; Eimoto T; Nagaya S; Tateyama H
    Histopathology; 2006 Jun; 48(7):801-7. PubMed ID: 16722928
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Minichromosome maintenance protein 2 (MCM2) is a stronger discriminator of increased proliferation in mucosa adjacent to colorectal cancer than Ki-67.
    Hanna-Morris A; Badvie S; Cohen P; McCullough T; Andreyev HJ; Allen-Mersh TG
    J Clin Pathol; 2009 Apr; 62(4):325-30. PubMed ID: 18474544
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The potential role of Bcl-2 expression, apoptosis and cell proliferation (Ki-67 expression) in cases of gastric carcinoma and correlation with classic prognostic factors and patient outcome.
    Tsamandas AC; Kardamakis D; Tsiamalos P; Liava A; Tzelepi V; Vassiliou V; Petsas T; Vagenas K; Zolota V; Scopa CD
    Anticancer Res; 2009 Feb; 29(2):703-9. PubMed ID: 19331225
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Survivin expression in gastric cancer: Association with histomorphological response to neoadjuvant therapy and prognosis.
    Vallböhmer D; Drebber U; Schneider PM; Baldus S; Bollschweiler E; Brabender J; Warnecke-Eberz U; Mönig S; Hölscher AH; Metzger R
    J Surg Oncol; 2009 Jun; 99(7):409-13. PubMed ID: 19347901
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparison of radiological and pathohistological response to neoadjuvant chemotherapy combined with regional hyperthermia (RHT) and study of response dependence on the applied thermal parameters in patients with soft tissue sarcomas (STS).
    Stahl R; Wang T; Lindner LH; Abdel-Rahman S; Santl M; Reiser MF; Issels RD
    Int J Hyperthermia; 2009 Jun; 25(4):289-98. PubMed ID: 19670096
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The prognostic value of lymph node metastases and tumour regression grade in rectal cancer patients treated with long-course preoperative chemoradiotherapy.
    Lindebjerg J; Spindler KL; Ploen J; Jakobsen A
    Colorectal Dis; 2009 Mar; 11(3):264-9. PubMed ID: 18573119
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Immunoexpression of inhibitors of apoptosis proteins and their antagonist SMAC/DIABLO in colorectal carcinoma: correlation with apoptotic index, cellular proliferation and prognosis.
    De Oliveira Lima F; De Oliveira Costa H; Barrezueta LF; Fujiyama Oshima CT; Silva JA; Gomes TS; Pinheiro N; Neto RA; Franco M
    Oncol Rep; 2009 Aug; 22(2):295-303. PubMed ID: 19578769
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparative analysis of prognostic significance of molecular markers of apoptosis with clinical stage and tumor differentiation in patients with colorectal cancer: a single institute experience.
    Ivanov K; Kolev N; Tonev A; Nikolova G; Krasnaliev I; Softova E; Tonchev A
    Hepatogastroenterology; 2009; 56(89):94-8. PubMed ID: 19453036
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Tumor budding in tumor invasive front predicts prognosis and survival of patients with esophageal squamous cell carcinomas receiving neoadjuvant chemotherapy.
    Miyata H; Yoshioka A; Yamasaki M; Nushijima Y; Takiguchi S; Fujiwara Y; Nishida T; Mano M; Mori M; Doki Y
    Cancer; 2009 Jul; 115(14):3324-34. PubMed ID: 19452547
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The correlation between tumour regression grade and lymph node status after chemoradiation in rectal cancer.
    Berho M; Oviedo M; Stone E; Chen C; Nogueras J; Weiss E; Sands D; Wexner S
    Colorectal Dis; 2009 Mar; 11(3):254-8. PubMed ID: 18513188
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of short-term finasteride on apoptotic factors and androgen receptors in prostate cancer cells.
    Bass R; Perry B; Langenstroer P; Thrasher JB; Dennis KL; Tawfik O; Holzbeierlein J
    J Urol; 2009 Feb; 181(2):615-9; discussion 619-20. PubMed ID: 19091346
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Preoperative evaluation of the efficacy of radio-hyperthermo-chemotherapy for soft tissue sarcoma in a case series.
    Aiba H; Yamada S; Mizutani J; Yamamoto N; Okamoto H; Hayashi K; Kimura H; Takeuchi A; Miwa S; Higuchi T; Abe K; Taniguchi Y; Araki Y; Tsuchiya H; Otsuka T
    PLoS One; 2018; 13(4):e0195289. PubMed ID: 29659611
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Interdigitating dendritic cell sarcoma of lower extremities resistant to high dose chemotherapy BEAM with peripheral blood stem cell transplantation].
    Adam Z; Veselý K; Krejcí M; Pour L; Fakan F; Soumarová R; Neubauer J; Vanícek J; Cerný J; Kren L; Bolcák K; Smardová L; Hájek R; Mayer J
    Vnitr Lek; 2009 Feb; 55(2):147-57. PubMed ID: 19348397
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Methylation of protocadherin 10, a novel tumor suppressor, is associated with poor prognosis in patients with gastric cancer.
    Yu J; Cheng YY; Tao Q; Cheung KF; Lam CN; Geng H; Tian LW; Wong YP; Tong JH; Ying JM; Jin H; To KF; Chan FK; Sung JJ
    Gastroenterology; 2009 Feb; 136(2):640-51.e1. PubMed ID: 19084528
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Minichromosome maintenance protein 2 is a reliable proliferative marker in breast carcinoma.
    Reena RM; Mastura M; Siti-Aishah MA; Munirah MA; Norlia A; Naqiyah I; Rohaizak M; Sharifah NA
    Ann Diagn Pathol; 2008 Oct; 12(5):340-3. PubMed ID: 18774496
    [TBL] [Abstract][Full Text] [Related]  

  • 19. 11C-methionine vs. 18F-FDG PET in soft tissue sarcoma patients treated with neoadjuvant therapy: preliminary results.
    Ghigi G; Micera R; Maffione AM; Castellucci P; Cammelli S; Ammendolia I; Nanni C; Barbieri E; Grassetto G; Fanti S; Rubello D
    In Vivo; 2009; 23(1):105-10. PubMed ID: 19368133
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Prognostic factors for 72 patients with osteosarcoma of the extremity treated with neoadjuvant chemotherapy].
    Liu J; Guo W; Yang RL; Tang XD; Yang Y
    Zhonghua Wai Ke Za Zhi; 2008 Aug; 46(15):1166-70. PubMed ID: 19094683
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.